Gene Expression Profile as a Therapeutic Biomarker for Classic Hodgkin Lymphoma Treated with Immunotherapy-Based Regimens

被引：0
|
作者：
Zorilla, Leticia G. Hamana [1 ]
Lee, Hun [1 ]
Schmidt, Joo [1 ]
Kamel, Serageldin [1 ]
Rabassedas, Maria Neus Bota [1 ]
Sanchez-Espiridion, Beatriz [1 ]
Shen, Li [1 ]
Wang, Jing [1 ]
Wistuba, Ignacio [1 ]
Soto, Luisa Solis [1 ]
Vega, Francisco [1 ]
Marques-Piubelli, Mario L. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1114
引用
收藏
页码：S1143 / S1144
页数：2
相关论文
共 50 条
  • [31] Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association
    Fan, W
    Bubman, D
    Chadburn, A
    Harrington, WJ
    Cesarman, E
    Knowles, DM
    JOURNAL OF VIROLOGY, 2005, 79 (02) : 1244 - 1251
  • [32] Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association
    Fan, W
    Bubman, D
    Chadburn, A
    Cesarman, E
    Knowles, DM
    MODERN PATHOLOGY, 2003, 16 (01) : 231A - 232A
  • [33] Cytokine gene expression and T-cell transcription factor profile of the T-cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma
    Atayar, C.
    Poppema, S.
    Blokzijl, T.
    Boot, M.
    Gascoyne, R. D.
    Visser, L.
    van den Berg, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 2 - 2
  • [34] The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery
    Yue, Chao
    Lian, Wenqin
    Duan, Mengying
    Xia, Die
    Cao, Xianbin
    Peng, Jianzhong
    ENVIRONMENTAL TOXICOLOGY, 2024, 39 (03) : 1858 - 1873
  • [35] A gene expression-based model predicts outcome in chil-dren with intermediate-risk classical Hodgkin lymphoma
    Johnston, Rebecca L.
    Mottok, Anja
    Chan, Fong Chun
    Jiang, Aixiang
    Diepstra, Arjan
    Visser, Lydia
    Telenius, Adele
    Gascoyne, Randy D.
    Friedman, Debra L.
    Schwartz, Cindy L.
    Kelly, Kara M.
    Scott, David W.
    Horton, Terzah M.
    Steidl, Christian
    BLOOD, 2022, 139 (06) : 889 - 893
  • [36] Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma:: increased interferon-α/β-inducible gene expression, without significant toxicity
    Friedberg, JW
    Kim, H
    McCauley, M
    Hessel, EM
    Sims, P
    Fisher, DC
    Nadler, LM
    Coffman, RL
    Freedman, AS
    BLOOD, 2005, 105 (02) : 489 - 495
  • [37] Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association.
    Wen, F
    Bubman, D
    Chadburn, A
    Cesarman, E
    Knowles, DM
    BLOOD, 2002, 100 (11) : 316A - 316A
  • [38] GENE EXPRESSION PROFILES OF LYMPHOCYTES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCC) TREATED WITH DENDRITIC CELL (DC)-BASED IMMUNOTHERAPY
    Schwaab, Thomas
    Wolf, Benita
    Schwarzer, Adrian
    Hampton, Thomas
    Fisher, Jan
    Gui, Jiang
    Seigne, John
    Ernstoff, Marc
    JOURNAL OF UROLOGY, 2010, 183 (04): : E698 - E698
  • [39] RETRACTION: Alterations in cytokine gene expression profile in colon mucosa of inflammatory bowel disease patients on different therapeutic regimens (Retraction of Vol 92, Pg 12, 2017)
    Velikova, Tsvetelina
    Kyurkchiev, Dobroslav
    Spassova, Zoya
    Karakolev, Iliya
    Ivanova-Todorova, Ekaterina
    Altankova, Iskra
    Stanilova, Spaska
    CYTOKINE, 2020, 129
  • [40] Efficacy of 90Y-Ibritumomab Tiuxetan in the Older Population with Non-Hodgkin Lymphoma Pre-Treated with Rituximab-Based Regimens: A Single-Institution Experience
    Agrawal, Vaibhav
    Diane, Smelser T.
    Castillo, Jose I.
    Raup, Kelly
    Treanna, Girton D.
    Collins, Scotty R.
    Brady, James O.
    Khan, Sharif S.
    BLOOD, 2017, 130
12345